Risk factors for adverse reactions from contrast agents for computed tomography

BackgroundSymptoms of an adverse reaction to contrast agents for computed tomography are diverse ranging, and sometimes serious. The goal of this study is to create a scoring rule to predict adverse reactions to contrast agents used in computed tomography.MethodsThis was a retrospective cohort study of all adult patients undergoing contrast enhanced CT scan for 7 years. The subjects were randomly divided into either a derivation or validation group. Baseline data and clinically relevant factors were collected from the electronic chart. Primary outcome was any acute adverse reactions to contrast media, observed for during 24 hours after administration. All potential candidate predictors were included in a forward stepwise logistic regression model. Prediction scores were assigned based on β coefficient. A receiver operating characteristic (ROC) curve was drawn, and the area under the curve (AUC) and incidence of acute adverse reactions at each point were obtained. The same process was performed in the validation group.Results36,472 patients underwent enhanced CT imaging: 20,000 patients in the derivation group and 16,472 in the validation group. A total of 409 (2.0%, 95% CI:1.9-2.3) and 347 (2.1%, 95% CI:1.9-2.3) acute adverse reactions were seen in the derivation and validation groups. Logistic regression analysis revealed that prior adverse reaction to contrast agents, urticaria, an allergic history to drugs other than contrast agents, contrast agent concentration >70%, age <50 years, and total contrast agent dose >65 g were significant predictors of an acute adverse reaction. AUC was 0.70 (95% CI:0.67-0.73) and 0.67 (95% CI:0.64-0.70) in the derivation and validation groups.ConclusionsWe suggest a prediction model consisting of six predictors for acute adverse reactions to contrast agents used in CT.

[1]  D. Swanson,et al.  Ionic versus nonionic contrast media: a prospective study of the effect of rapid bolus injection on nausea and anaphylactoid reactions. , 1998, Journal of computer assisted tomography.

[2]  G W Hartman,et al.  Acute reactions to urographic contrast medium: incidence, clinical characteristics and relationship to history of hypersensitivity states. , 1973, The American journal of roentgenology, radium therapy, and nuclear medicine.

[3]  T. Mikami,et al.  Studies on experimental iodine allergy: 2. Iodinated protein antigens and their generation from inorganic and organic iodine-containing chemicals. , 2004, The Journal of toxicological sciences.

[4]  K. Nishizawa,et al.  [Survey of CT practice in Japan and collective effective dose estimation]. , 2004, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica.

[5]  P. Finn,et al.  Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization. , 2001, American heart journal.

[6]  J. Ellis,et al.  Repeat contrast medium reactions in premedicated patients: frequency and severity. , 2009, Radiology.

[7]  C. Kuhl,et al.  Adverse events after unenhanced and monomeric and dimeric contrast-enhanced CT: a prospective randomized controlled trial. , 2006, Radiology.

[8]  M. Smith.  Adverse reactions to ionic and nonionic contrast media , 1991 .

[9]  T. Kozuka,et al.  Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. , 1990, Radiology.

[10]  N. Ban,et al.  ESTIMATION OF THE NUMBER OF CT PROCEDURES BASED ON A NATIONWIDE SURVEY IN JAPAN , 2011, Health physics.

[11]  R. Patterson,et al.  Prophylaxis against repeated radiocontrast media reactions in 857 cases. Adverse experience with cimetidine and safety of beta-adrenergic antagonists. , 1985, Archives of internal medicine.

[12]  R. Patterson,et al.  Adverse reactions to radiocontrast media. , 1988, Progress in cardiovascular diseases.

[13]  S. Cochran.  Anaphylactoid reactions to radiocontrast media , 2005, Current allergy and asthma reports.

[14]  J. Donnal,et al.  Myelography complications and current practice patterns. , 2005, AJR. American journal of roentgenology.

[15]  H. Schild,et al.  Contrast-media-induced hypersensitivity or allergic/allergic-like reactions? Suggestion for a more appropriate use of the nomenclature , 2008, European Journal of Clinical Pharmacology.

[16]  T Heeren,et al.  Adverse events with radiographic contrast agents: results of the SCVIR Contrast Agent Registry. , 1997, Radiology.

[17]  J. Bousquet,et al.  Skin test reactivity to histamine from infancy to old age. , 1987, The Journal of allergy and clinical immunology.

[18]  J. Ellis,et al.  Treatment of adverse reactions to radiographic contrast media in adults. , 1996, Radiologic clinics of North America.

[19]  Rebecca S Lewis,et al.  Projected cancer risks from computed tomographic scans performed in the United States in 2007. , 2009, Archives of internal medicine.

[20]  E. S. Pearson,et al.  THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL , 1934 .

[21]  D. Brenner,et al.  Estimated risks of radiation-induced fatal cancer from pediatric CT. , 2001, AJR. American journal of roentgenology.

[22]  Ian Tritschler MrPharmS.  Contrast media reactions. , 1994, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[23]  B. Barrett.  Contrast nephrotoxicity. , 1994, Journal of the American Society of Nephrology : JASN.

[24]  E C Lasser,et al.  Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration. , 1997, Radiology.

[25]  K. Klose,et al.  Hypersensitivity reactions and contrast medium injection: are they always related? , 2011, European journal of radiology.

[26]  J. Habbema,et al.  Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. , 2001, Journal of clinical epidemiology.

[27]  J. Hagan.  Anaphylactoid and adverse reactions to radiocontrast agents. , 2004, Immunology and allergy clinics of North America.

[28]  Amy Berrington de González,et al.  Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries , 2004, The Lancet.

[29]  R. Patterson,et al.  The prevention of immediate generalized reactions to radiocontrast media in high-risk patients. , 1991, The Journal of allergy and clinical immunology.